Rosa Biotech secures £415,000 to accelerate early disease screening

By SETsquared-Bristol | 24th May 2023
Three Rosa Biotech scientists in lab looking at samples

Bio-sensing pioneer Rosa Biotech has secured £415,000 from angel investors and announced plans to accelerate development of its bio-sensing technology, designed to enable cost effective, early-stage screening of a range of life-threatening diseases. The University of Bristol healthtech spinout joined SETsquared Bristol in February 2023. It is initially targeting the early identification of non-alcoholic fatty…

Read More